23andMe SPAC Presentation Deck slide image

23andMe SPAC Presentation Deck

Health Predispositions 14 Including: Type 2 Diabetes (Powered by 23andMe Research) Celiac Disease Uterine Fibroids Our Health Service The First and Only Multi-Disease DTC Genetic Service That Includes FDA-Authorized Reports and Provides Personalized Genetic Insights and Tools Chronic Kidney Disease G6PD Deficiency MUTYH-Associated Polyposis BRCA1/BRCA2 (selected variants) Type 2 Diabetes YOUR RESULT Your genetics are associated with a typical likelihood. DDC Genetics # Age 37% HH Ethnicity ¹ Wellness information does not require FDA Authorization. Wellness¹ 8 Including: Muscle Composition Genetic Weight Alcohol Flush Reaction Saturated Fat and Weight Sleep Movement Genetic Weight YOUR RESULT Your genes predispose you to weigh about 7% less than average. Average 142 5'4" ▬▬▬▬▬▬▬ Carrier Status 40+ Including: Cystic Fibrosis Sickle Cell Anemia Familial Hyperinsulinism (ABCC8-Related) Tay-Sachs Disease Glycogen Storage Disease (Type 1a) Tay-Sachs Disease YOUR RESULT You do not have the variants we tested. 0 variants detected in the HEXA gene 6 FDA Authorizations Pharmacogenetics 3 Including: SLCO1B1 Drug Transport CYP2C19 Drug Metabolism DPYD Drug Metabolism 23andMe+ Pharmacogenetics Genetic variants may influence how you process medications. YOUR RESULTS CYP2C19 Drug Metabolism LIKELY NORMAL METABOLIZER ( DPYD Drug Metabolism LIKELY NORMAL METABOLIZER SLC01B1 Drug Transport LIKELY NORMAL METABOLIZER Print summary 23and Me Confidential and Proprietary Information 14
View entire presentation